AFLP generates unique DNA fingerprints by analyzing polymorphic bands through selective amplification and is widely used in forensic identification and paternity testing.

mRNA vaccines can be designed and produced rapidly, manufactured at scale, and trigger robust immune responses without requiring actual pathogenic agents.

The Human Genome Project provided the complete human genetic blueprint, revolutionizing our understanding of genetic diseases and enabling personalized medicine approaches.

Nanopore sequencing allows real-time DNA reading as strands pass through nanopores, enabling rapid and cost-effective long-read sequencing without amplification.

Synthetic biology raises significant biosafety and biosecurity concerns regarding uncontrolled release of synthetic organisms, potential ecological disruption, and dual-use implications.

PCR works through repeated cycles of three temperatures: denaturation (95°C), annealing (50-65°C), and extension (72°C), with Taq polymerase extending primers exponentially.

DNA microarrays can detect antibiotic resistance genes rapidly by analyzing the genetic profile of bacteria, enabling faster identification compared to traditional culture methods.

Hybridomas combine the antibody-producing capability of B cells with the immortality of myeloma cancer cells, producing monoclonal antibodies of high specificity indefinitely.

Modified viral vectors with pathogenic genes removed can efficiently deliver therapeutic genes to target cells while being non-pathogenic and reducing immune rejection.

Embryonic stem cells (ESCs) are pluripotent, meaning they can self-renew indefinitely and differentiate into any type of cell in the body, making them valuable for regenerative medicine.